Ipsen en Skyhawk Therapeutics kondigen samenwerking aan op het gebied van onderzoek naar RNA-targeting bij zeldzame neurologische aandoeningen
IPSEN SA S/ADR (IPSEY)
NASDAQ:AMEX Investor Relations:
ipsen.com/investors
Company Research
Source: PR Newswire
Ipsen gaat een optieovereenkomst aan om exclusieve wereldwijde rechten te verkrijgen voor twee kandidaten die worden onderzocht in het kader van de samenwerking.Na validatie van de ontwikkelingskandidaten neemt Ipsen de verantwoordelijkheid op zich voor de verdere ontwikkeling en commercialisering, waarbij gebruik wordt gemaakt van de bestaande expertise binnen de neurowetenschappen met betrekking tot bewegingsstoornissen.Deze veelbelovende platformtechnologie van Skyhawk maakt het mogelijk om RNA-targets die voorheen niet met geneesmidelen konden worden behandeld te verkennen met behulp van kleine moleculen, waardoor meer aandoeningen behandelbaar worden1PARIJS en BOSTON, 23 april 2024 /PRNewswire/ -- Ipsen (Euronext: IPN; ADR: IPSEY) en Skyhawk Therapeutics hebben vandaag de ondertekening bekendgemaakt van een exclusieve wereldwijde samenwerkingsovereenkomst voor onderzoek en ontwikkeling op het gebied van nieuwe kleine moleculen waarmee RNA kan worden gemoduleerd voor de behandelin
Show less
Read more
Impact Snapshot
Event Time:
IPSEY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPSEY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPSEY alerts
High impacting IPSEN SA S/ADR news events
Weekly update
A roundup of the hottest topics
IPSEY
News
- Ipsen appoints Keira Driansky as EVP, President of North AmericaGlobeNewswire
- Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidanceGlobeNewswire
- Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesPR Newswire
- Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesPR Newswire
- Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseasesGlobeNewswire